Evidence map›Paper›PMID 25169753›Full record

ArticleAmerican journal of medical genetics. Part C, Seminars in medical genetics2014

The transcriptional regulator ADNP links the BAF (SWI/SNF) complexes with autism.

Geert Vandeweyer, Céline Helsmoortel, Anke Van Dijck, Anneke T Vulto-van Silfhout, Bradley P Coe, Raphael Bernier, Jennifer Gerdts, Liesbeth Rooms, Jenneke van den Ende, Madhura Bakshi and 10 more

Open access · greenAbstract read
In one paragraph

Article in American journal of medical genetics. Part C, Seminars in medical genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. In-Depth Genomic Analysis: The New Challenge in Congenital Heart Disease.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Whole genome sequencing of 45 Japanese patients with intellectual disability.American journal of medical genetics. Part A · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 5 countries.

Geert Vandeweyer
Céline Helsmoortel
Anke Van Dijck
Anneke T Vulto-van Silfhout
Bradley P Coe
Raphael Bernier
Jennifer Gerdts
Liesbeth Rooms
Jenneke van den Ende
Madhura Bakshi
Meredith Wilson
Ann Nordgren
Laura G Hendon
Omar A Abdulrahman
Corrado Romano
Bert B A de Vries
Tjitske Kleefstra
Evan E Eichler
Nathalie Van der Aa
R Frank Kooy
Radboud University Nijmegen · NLUniversity of Antwerp · BEUniversity of Washington · USBoston Children's Hospital · USUniversity of Mississippi · USAntwerp University Hospital · BEHoward Hughes Medical Institute · USKarolinska Institutet · SEOasi Maria SS · IT

Funding

Sporadic Mutations and Autism Spectrum DisordersR01MH101221 · NIMH · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2013 to 2025
$9.2M
Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 2014 to 2019
$7.9M
Howard Hughes Medical InstituteNICHD NIH HHS U54 HD083091NIMH NIH HHS MH101221NIMH NIH HHS R01 MH101221
6 · The paper itself

Abstract

Mutations in ADNP were recently identified as a frequent cause of syndromic autism, characterized by deficits in social communication and interaction and restricted, repetitive behavioral patterns. Based on its functional domains, ADNP is a presumed transcription factor. The gene interacts closely with the SWI/SNF complex by direct and experimentally verified binding of its C-terminus to three of its core components. A detailed and systematic clinical assessment of the symptoms observed in our patients allows a detailed comparison with the symptoms observed in other SWI/SNF disorders. While the mutational mechanism of the first 10 patients identified suggested a gain of function mechanism, an 11th patient reported here is predicted haploinsufficient. The latter observation may raise hope for therapy, as addition of NAP, a neuroprotective octapeptide named after the first three amino acids of the sequence NAPVSPIQ, has been reported by others to ameliorate some of the cognitive abnormalities observed in a knockout mouse model. It is concluded that detailed clinical and molecular studies on larger cohorts of patients are necessary to establish a better insight in the genotype phenotype correlation and in the mutational mechanism.

Indexed as

MutationAbnormalities, MultipleAnimalsAutistic DisorderChild, PreschoolDNA HelicasesFaceHand Deformities, CongenitalHaploinsufficiencyHomeodomain ProteinsHumansInfantIntellectual DisabilityMice, KnockoutMicrognathismNeckADNP protein, humanAdnp protein, mousedavunetideDNA HelicasesHomeodomain ProteinsNerve Tissue ProteinsNuclear ProteinsOligopeptidesSMARCA2 protein, humanSMARCA4 protein, humanTranscription FactorsADNPautismBAF complexesSWI/SNF

Identifiers

PMID25169753
PMCPMC4195434
OpenAlexW1787127084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.